☆ 4.7 Article

Nitazoxanide potentiates linezolid against linezolid-resistant Staphylococcus aureus in vitro and in vivo

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Christopher J. L. Murray et al.

Summary: Antimicrobial resistance (AMR) poses a significant threat to global human health, and this study provides the most comprehensive estimates of AMR burden to date. By estimating deaths and disability-adjusted life-years (DALYs) associated with bacterial AMR in 204 countries and territories in 2019, the study highlights the impact of resistance and the leading pathogen-drug combinations contributing to it.

LANCET (2022)

Add to Collection

Article Infectious Diseases

Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey

Sara Tomczyk et al.

Summary: The survey on the global impact of COVID-19 on AMR among GLASS countries revealed reduced availability of healthcare and cleaning staff, which could bias AMR surveillance data. Additionally, most countries still lack complete data to measure the specific impact of COVID-19 on AMR rates.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Add to Collection

Review Microbiology

Drug repurposing for antimicrobial discovery

Maya A. Farha et al.

NATURE MICROBIOLOGY (2019)

Add to Collection

Article Infectious Diseases

Repurposing disulfiram for treatment of Staphylococcus aureus infections

Ritesh Thakare et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)

Add to Collection

Editorial Material Microbiology

Update on drug-repurposing: is it useful for tackling antimicrobial resistance?

Grace Kaul et al.

FUTURE MICROBIOLOGY (2019)

Add to Collection

Review Microbiology

Antibiotic resistance in Staphylococcus aureus. Current status and future prospects

Timothy J. Foster

FEMS MICROBIOLOGY REVIEWS (2017)

Add to Collection

Article Infectious Diseases

Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid

Katie E. Barber et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)

Add to Collection

Article Microbiology

Nitazoxanide Stimulates Autophagy and Inhibits mTORC1 Signaling and Intracellular Proliferation of Mycobacterium tuberculosis

Karen K. Y. Lam et al.

PLOS PATHOGENS (2012)

Add to Collection

Article Microbiology

Nitazoxanide Inhibits Biofilm Formation by Staphylococcus epidermidis by Blocking Accumulation on Surfaces

Florence Tchouaffi-Nana et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Add to Collection

Article Microbiology

Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni

Paul S. Hoffman et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.